未找到相关数据
The ELiPSE-1 study: A phase 1, multicenter, open-label study of CNTY-101 in subjects with relapsed or refractory CD19-positive B-cell malignancies.
被引：0
作者：
Patel, Krish
Rothman, Sarah
Das, Poulomee A.
Yee, Stephanie
Ramachandran, Indu
Koumenis, Iphigenia
Cook, Terry A.
Yuan, Ying
Trede, Nikolaus S.
Mattour, Ahmad Hatem
机构：
[1] Swedish Canc Inst, Ctr Blood Disorders & Cellular Therapy, Seattle, WA USA
[2] Century Therapeut, Philadelphia, PA USA
[3] Century Therapeut, Seattle, WA USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[5] Henry Ford Hlth Syst, Detroit, MI USA
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS7580
引用
收藏
页数：1
相关论文